Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways. [electronic resource]
Producer: 20030403Description: 1281-93 p. digitalISSN:- 0950-9232
- Animals
- Apoptosis -- drug effects
- Apoptosis Regulatory Proteins
- Bcl-2-Like Protein 11
- Butadienes -- pharmacology
- Carrier Proteins -- biosynthesis
- Cell Line -- drug effects
- Chromones -- pharmacology
- Cricetinae
- Cricetulus
- Culture Media, Serum-Free -- pharmacology
- Cycloheximide -- pharmacology
- Cysteine Endopeptidases -- pharmacology
- Cysteine Proteinase Inhibitors -- pharmacology
- Dactinomycin -- pharmacology
- Enzyme Activation -- drug effects
- Enzyme Inhibitors -- pharmacology
- Fibroblasts -- metabolism
- JNK Mitogen-Activated Protein Kinases
- Lung
- Membrane Proteins
- Mitogen-Activated Protein Kinase 1 -- antagonists & inhibitors
- Mitogen-Activated Protein Kinase 3
- Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Morpholines -- pharmacology
- Nitriles -- pharmacology
- Nucleic Acid Synthesis Inhibitors -- pharmacology
- Phosphatidylinositol 3-Kinases -- physiology
- Phosphoinositide-3 Kinase Inhibitors
- Protein Serine-Threonine Kinases -- genetics
- Protein Structure, Tertiary
- Protein Synthesis Inhibitors -- pharmacology
- Proto-Oncogene Proteins -- metabolism
- Proto-Oncogene Proteins c-bcl-2
- Proto-Oncogene Proteins c-raf -- genetics
- RNA, Messenger -- biosynthesis
- Recombinant Fusion Proteins -- metabolism
- Signal Transduction -- drug effects
- bcl-2-Associated X Protein
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.